Salt-Inducible Kinase Inhibitors as a Molecular Approach to Fracture Repair
Wednesday, October 18, 2023
3:52 PM – 3:58 PM PST
Disclosure(s): AstraZeneca: Consultant (Ongoing); Galapagos NV: Consultant (Ongoing); Radius Health: Grant or Research Support, or I am listed as the PI (Ongoing)